We are live on
!
Find out more
BTW
Boston Trust Walden Portfolio holdings
AUM
$13.1B
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
(+8.9%)
Cap. Flow
+$201M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$33.2M |
| 2 |
TE Connectivity
TEL
|
+$33.1M |
| 3 |
Helen of Troy
HELE
|
+$29.2M |
| 4 |
Columbia Banking Systems
COLB
|
+$25M |
| 5 |
Cavco Industries
CVCO
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$52.2M |
| 2 |
Bruker
BRKR
|
+$42.9M |
| 3 |
Williams-Sonoma
WSM
|
+$40.5M |
| 4 |
3M
MMM
|
+$34.1M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.74% |
| 2 | Financials | 16.42% |
| 3 | Healthcare | 14.76% |
| 4 | Industrials | 14.05% |
| 5 | Consumer Discretionary | 10.65% |
Similar funds
TWIM
PFPG
RCMU
EPFB
NMIFOAC
AAMU
MGIA
TG
Boston Trust Walden's Q2 2021 Portfolio in Review
As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
- Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
- Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
- Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
- Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
- Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
- Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.
Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.